Page 9 - Solid Biosciences Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) and Telix Pharmaceuticals (OTCMKTS:TLPPF – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, institutional ownership, risk and analyst recommendations. Valuation & Earnings This table compares Ultragenyx Pharmaceutical […]

- Dr. Brooks is a veteran drug development leader whose experience includes roles at Pfizer, 4D Molecular Therapeutics, and Gilead Life Sciences, ...

STATEMENT OF EXECUTIVE COMPENSATION This Statement of Executive Compensation is filed by ImmunoPrecise Antibodies Ltd. pursuant to Section 11.6 of National...

Great Point Partners LLC acquired a new stake in shares of Solid Biosciences Inc. (NASDAQ:SLDB – Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 210,405 shares of the company’s stock, valued at approximately $997,000. Great Point Partners LLC owned […]

/PRNewswire/ -- The Duchenne muscular dystrophy (DMD) therapeutics market size is expected to grow by USD 2.39 billion from 2022 to 2027. In addition, the...